These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 36569153)
1. Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis. Moro F; Mariotti F; Pira A; De Luca N; Didona B; Pagnanelli G; Di Zenzo G Front Med (Lausanne); 2022; 9():1055045. PubMed ID: 36569153 [TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764 [TBL] [Abstract][Full Text] [Related]
3. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid. Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547 [TBL] [Abstract][Full Text] [Related]
4. Urticarial Lesions in a Pregnant Woman. Santos-Alarcón S; Benavente-Villegas C; García-Briz I; Moneva-Léniz M; Sanchis-Sánchez C; Mateu-Puchades A Acta Dermatovenerol Croat; 2018 Apr; 26(1):71-72. PubMed ID: 29782306 [TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP. Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674 [TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230. Muhammed N; Korgaonkar S; Pradhan V; Khopkar US Indian Dermatol Online J; 2021; 12(5):696-700. PubMed ID: 34667755 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid. Cole C; Borradori L; Amber KT Antibodies (Basel); 2022 Jun; 11(3):. PubMed ID: 35892704 [TBL] [Abstract][Full Text] [Related]
8. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice. Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818 [TBL] [Abstract][Full Text] [Related]
10. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders. Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R Front Immunol; 2021; 12():569287. PubMed ID: 33841390 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid. Lee EH; Kim YH; Kim S; Kim SE; Kim SC Ann Dermatol; 2012 Feb; 24(1):45-55. PubMed ID: 22363155 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid. Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605 [TBL] [Abstract][Full Text] [Related]
13. Anti-BP180 and anti-BP230 enzyme-linked immunosorbent assays for diagnosis and disease activity tracking of bullous pemphigoid: A prospective cohort study. Chanprapaph K; Ounsakul V; Pruettivorawongse D; Thadanipon K Asian Pac J Allergy Immunol; 2021 Dec; 39(4):272-278. PubMed ID: 31175713 [TBL] [Abstract][Full Text] [Related]
14. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996 [TBL] [Abstract][Full Text] [Related]
15. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity. van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid. Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641 [TBL] [Abstract][Full Text] [Related]
17. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345 [TBL] [Abstract][Full Text] [Related]
18. Case of pemphigoid vegetans with autoantibodies against the BP180 C-terminal domain and BP230 antigen. Doi C; Shiraishi K; Koga H; Ishii N; Sayama K J Dermatol; 2021 Aug; 48(8):1286-1290. PubMed ID: 34003521 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid. Tampoia M; Lattanzi V; Zucano A; Villalta D; Filotico R; Fontana A; Vena GA; Di Serio F Ann N Y Acad Sci; 2009 Sep; 1173():15-20. PubMed ID: 19758126 [TBL] [Abstract][Full Text] [Related]